Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose-lowering therapies.
Jesper HallasJacob H AndersenJens SøndergaardLotte RasmussenHelene KildegaardTina VilsbøllReimar W ThomsenPublished in: Diabetes, obesity & metabolism (2024)
Our study documents a trend towards earlier T2D treatment intensification and an increase in the use of GLP-1RAs and SGLT-2is in Denmark. However, optimal T2D treatment is still not received by most individuals with early T2D and established cardiorenal disease.